Canada - English - Health Canada

bristol-myers squibb canada - fedratinib (fedratinib hydrochloride) - capsule - 100mg - fedratinib (fedratinib hydrochloride) 100mg - antineoplastic agents

European Union - English - EMA (European Medicines Agency)

bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antineoplastic agents - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.

Singapore - English - HSA (Health Sciences Authority)

bristol-myers squibb (singapore) pte. ltd. - fedratinib dihydrochloride monohydrate eqv fedratinib - capsule - fedratinib dihydrochloride monohydrate eqv fedratinib 100 mg